Literature DB >> 9493802

Influence of recent antibiotic therapy on antimicrobial resistance of Streptococcus pneumoniae in children with acute otitis media in Spain.

F del Castillo1, F Baquero-Artigao, A Garcia-Perea.   

Abstract

BACKGROUND: Despite the high prevalence of penicillin resistance among Streptococcus pneumoniae strains in Spain (40 to 60% with MIC > or = 0.1 microg/ml), the data on acute otitis media (AOM) isolates are scarce. We conducted a prospective, longitudinal study to determine the rates of antimicrobial resistance of S. pneumoniae isolates from children with AOM in our country and to analyze the effect of previous antibiotic therapy on these rates.
METHODS: Tympanocentesis was performed on 169 children diagnosed with AOM (age range, 1 month to 14 years). Two groups were considered: Group A, 113 patients with non-antibiotic-treated AOM, subdivided into Group A1 (collected from 1989 to 1992) and Group A2 (1992 to 1996); Group B, 56 patients from the period 1992 to 1996, with AOM clinical failure, defined as worsening or persistent symptoms after at least 2 days of appropriate antibiotic therapy. Amoxicillin-clavulanate was the most frequent antibiotic used (68%), followed by azithromycin (21%), cefaclor and cefixime (11%).
RESULTS: A total of 63 S. pneumoniae isolates were recovered, 42 in Group A and 21 in Group B. Resistance to penicillin (MIC > or = 0.1 microg/ml) was found in 38% of strains in Group A (32% in A1 and 50% in A2), but in Group B the rate of resistance reached 90% (P = 0.0002). Erythromycin resistance was also increased from 35% (Group A2) to 62% (Group B), and trimethoprim-sulfamethoxazole resistance rose from 64% to 81%.
CONCLUSIONS: Resistance to penicillin among S. pneumoniae AOM isolates is frequent and is increasing in Spain. After failure of standard antibiotic therapy, the rates of penicillin resistance reached 90% of the isolates.

Entities:  

Mesh:

Year:  1998        PMID: 9493802     DOI: 10.1097/00006454-199802000-00003

Source DB:  PubMed          Journal:  Pediatr Infect Dis J        ISSN: 0891-3668            Impact factor:   2.129


  9 in total

Review 1.  Management of acute otitis media in the 1990s: the decade of resistant pneumococcus.

Authors:  S L Block
Journal:  Paediatr Drugs       Date:  1999 Jan-Mar       Impact factor: 3.022

2.  Multiplex PCR to determine Streptococcus pneumoniae serotypes causing otitis media in the Republic of Ireland with further characterisation of antimicrobial susceptibilities and genotypes.

Authors:  I Vickers; D O'Flanagan; M Cafferkey; H Humphreys
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2010-11-13       Impact factor: 3.267

3.  Multiple mutations modulate the function of dihydrofolate reductase in trimethoprim-resistant Streptococcus pneumoniae.

Authors:  J P Maskell; A M Sefton; L M Hall
Journal:  Antimicrob Agents Chemother       Date:  2001-04       Impact factor: 5.191

4.  Optimal dose of amoxicillin in treatment of otitis media caused by a penicillin-resistant pneumococcus strain in the gerbil model.

Authors:  Araceli Parra; Carmen Ponte; Carlos Cenjor; Gloria García-Calvo; María José Giménez; Lorenzo Aguilar; Francisco Soriano
Journal:  Antimicrob Agents Chemother       Date:  2002-03       Impact factor: 5.191

5.  Analysis of penicillin-binding protein genes of clinical isolates of Streptococcus pneumoniae with reduced susceptibility to amoxicillin.

Authors:  Mignon du Plessis; Edouard Bingen; Keith P Klugman
Journal:  Antimicrob Agents Chemother       Date:  2002-08       Impact factor: 5.191

6.  Relationship with original pathogen in recurrence of acute otitis media after completion of amoxicillin/clavulanate: bacterial relapse or new pathogen.

Authors:  Ravinder Kaur; Janet R Casey; Michael E Pichichero
Journal:  Pediatr Infect Dis J       Date:  2013-11       Impact factor: 2.129

7.  Pharmacological treatment of acute otitis media in children. A comparison among seven locations: Tenerife, Barcelona and Valencia (Spain), Toulouse (France), Smolensk (Russia), Bratislava (Slovakia) and Sofia (Bulgaria).

Authors:  E Sanz; M A Hernández; M Kumari; S Ratchina; L Stratchounsky; M A Peiré; M Lapeyre-Mestre; B Horen; M Kriska; H Krajnakova; H Momcheva; D Encheva; I Martínez-Mir; V Palop
Journal:  Eur J Clin Pharmacol       Date:  2004-01-29       Impact factor: 2.953

8.  Beta-lactamase-producing nontypeable Haemophilus influenzae fails to protect Streptococcus pneumoniae from amoxicillin during experimental acute otitis media.

Authors:  Eva Westman; Susanne Lundin; Ann Hermansson; Asa Melhus
Journal:  Antimicrob Agents Chemother       Date:  2004-09       Impact factor: 5.191

9.  Aggregated antibiograms and monitoring of drug-resistant Streptococcus pneumoniae.

Authors:  Chris A Van Beneden; Catherine Lexau; Wendy Baughman; Brenda Barnes; Nancy Bennett; P Maureen Cassidy; Margaret Pass; Lisa Gelling; Nancy L Barrett; Elizabeth R Zell; Cynthia G Whitney
Journal:  Emerg Infect Dis       Date:  2003-09       Impact factor: 6.883

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.